{"gene":"DUSP16","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2001,"finding":"DUSP16/MKP-7 was identified as a novel dual-specificity phosphatase that binds to and inactivates JNK/SAPK and p38α/β MAPKs but not ERK; it is predominantly cytoplasmic when expressed in cultured cells; substrate specificity toward p38 isoforms was defined (α and β, but not γ or δ); the MAPK-docking site sequence was characterized.","method":"Co-immunoprecipitation, in-cell overexpression kinase assays, subcellular localization by immunofluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — replicated independently in two papers (PMID:11359773 and PMID:11489891), multiple orthogonal methods","pmids":["11359773"],"is_preprint":false},{"year":2001,"finding":"DUSP16/MKP-7 contains both a nuclear export signal (NES) and a nuclear localization signal (NLS) in its C-terminal stretch, making it the first leptomycin B-sensitive shuttle MKP; it resides exclusively in the cytoplasm under basal conditions but redistributes to the nucleus upon leptomycin B treatment or NES mutation; co-immunoprecipitation showed MKP-7 retains JNK/p38 in the cytoplasm.","method":"Leptomycin B treatment, NES mutant expression, subcellular fractionation/immunofluorescence, Co-IP","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in single paper, confirmed by independent lab (PMID:23280045)","pmids":["11489891"],"is_preprint":false},{"year":2005,"finding":"ERK phosphorylates DUSP16/MKP-7 at Ser-446 in the C-terminal stretch (CTS), stabilizing the protein by reducing proteasome-mediated degradation; deletion of the CTS elongates MKP-7 half-life; MKP-7 is polyubiquitinated and degraded via the proteasome pathway.","method":"35S-pulse labeling, proteasome inhibitor treatment, phospho-mimetic/deletion mutant expression, ubiquitin co-expression assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro/cell-based mutational analysis with multiple orthogonal methods","pmids":["15689616"],"is_preprint":false},{"year":2005,"finding":"DUSP16/MKP-7 binds the JNK3 scaffold protein β-arrestin 2 via MKP7 amino acids 394–443 (same region that interacts with JIP-1); MKP7 dephosphorylates JNK3 bound to β-arrestin 2 following ASK1 overexpression or AT1aR stimulation; AT1aR stimulation causes rapid (within 5 min) dissociation of MKP7 from β-arrestin 2, followed by reassociation on endocytic vesicles at 30–60 min.","method":"Co-immunoprecipitation, deletion mapping, receptor stimulation assays, immunofluorescence colocalization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with domain mapping and functional dephosphorylation readout","pmids":["15888437"],"is_preprint":false},{"year":2009,"finding":"miR-24 directly downregulates DUSP16/MKP-7, leading to enhanced phosphorylation of JNK and p38, stimulating myeloid cell proliferation and blocking granulocytic differentiation; this pathway is downstream of disrupted Runx1 subnuclear targeting.","method":"miRNA overexpression, western blot for phospho-JNK/p38, luciferase reporter, flow cytometry differentiation assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with defined cellular phenotype, direct miRNA-target validation","pmids":["19826043"],"is_preprint":false},{"year":2009,"finding":"SDF-1α-induced activation of eNOS leads to S-nitrosylation of DUSP16/MKP7, rendering the phosphatase inactive, which permits JNK3 activation required for endothelial cell migration.","method":"eNOS inhibition/knockdown, nitrosylation assay, JNK3 activity assay, endothelial migration assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — direct post-translational modification (S-nitrosylation) identified with functional consequence and epistasis","pmids":["19307591"],"is_preprint":false},{"year":2010,"finding":"MKP-7/DUSP16 blocks ERK-dependent nuclear gene activation by anchoring phosphorylated ERK in the cytoplasm, independent of its phosphatase catalytic activity toward ERK; a phosphatase-dead MKP-7 mutant similarly prolongs mitogen-induced ERK phosphorylation and prevents nuclear accumulation of phospho-ERK.","method":"Phosphatase-dead mutant overexpression, immunofluorescence colocalization, reporter gene assay, time-course ERK phosphorylation assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — functional mutant analysis with multiple readouts in a single lab","pmids":["20122898"],"is_preprint":false},{"year":2010,"finding":"DUSP16 expression is silenced by CpG island methylation in Burkitt's lymphoma (BL), which abrogates a negative feedback loop limiting JNK activity; in BL cell lines with DUSP16 methylation, JNK activation is increased, and cells show enhanced sensitivity to JNK-activating agents.","method":"Bisulfite sequencing, methylation-specific PCR, western blot with phospho-JNK antibody, siRNA knockdown","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — epigenetic mechanism identified with functional JNK pathway readout","pmids":["20551953"],"is_preprint":false},{"year":2011,"finding":"DUSP16 is selectively expressed in Th2 cells via histone H3/H4 acetylation at the dusp16 promoter; adenoviral overexpression of DUSP16 in naïve CD4+ T cells increased IL-4 and GATA-3 in Th2 and decreased IFNγ and T-bet in Th1 differentiation; dominant-negative DUSP16 had opposite effects; phosphatase activity is required for Th1/Th2 balance.","method":"ChIP, adenoviral transduction, dominant-negative mutant, cytokine ELISA, transgenic mouse immunization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including in vivo transgenic model and gain/loss-of-function","pmids":["21613215"],"is_preprint":false},{"year":2011,"finding":"MKP-7/DUSP16 silencing by siRNA increased phospho-JNK and inhibited VCAM-1 (but not ICAM-1) expression in TNF-α-stimulated endothelial cells; this regulation was mediated via IRF-1 binding to the VCAM-1 promoter, as confirmed by ChIP assay.","method":"siRNA knockdown, western blot, ChIP assay, flow cytometry","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA knockdown with ChIP-based pathway placement","pmids":["22182512"],"is_preprint":false},{"year":2012,"finding":"Mtb Eis protein acetylates Lys55 of DUSP16/MKP-7 (Nε-acetylation), which inhibits LPS-induced JNK phosphorylation; crystal structures of both Mtb and Msm Eis proteins explain the differential selectivity; this acetylation suppresses JNK-dependent autophagy, phagosome maturation, and ROS generation in macrophages.","method":"Biochemical acetyltransferase assay, crystal structure determination, site-directed mutagenesis, western blot for phospho-JNK, macrophage infection models","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus in vitro biochemistry and mutagenesis with functional readout","pmids":["22547814"],"is_preprint":false},{"year":2013,"finding":"In a rat cerebral ischemia/reperfusion model, MKP-7 is upregulated at 4 h reperfusion; MKP-7 nuclear export is required for cytoplasmic JNK inactivation (leptomycin B blocking nuclear export upregulated JNK activity); MKP-7 regulates JNK independently of the PI3K/Akt pathway.","method":"siRNA knockdown, cycloheximide treatment, leptomycin B treatment, subcellular fractionation, western blot for phospho-JNK in rat ischemia model","journal":"BMC neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo model with pharmacological and genetic perturbations","pmids":["23280045"],"is_preprint":false},{"year":2013,"finding":"PPARδ activation stabilizes DUSP16/MKP-7 mRNA (post-transcriptional mRNA stabilization), leading to suppression of JNK signaling and reduced UVB-induced MMP-1 secretion in human dermal fibroblasts and hairless mice.","method":"PPARδ siRNA knockdown, specific ligand treatment, western blot, mRNA stability assay, in vivo mouse model","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — mRNA stabilization mechanism with loss-of-function and in vivo confirmation","pmids":["23639976"],"is_preprint":false},{"year":2013,"finding":"Dusp16-deficient macrophages show selective overproduction of a subset of TLR-induced cytokines (including IL-12), mediated through enhanced JNK1/2 activation; JNK1/2 pharmacological inhibition or siRNA knockdown normalizes IL-12p40 secretion; Dusp16-deficient fibroblasts show enhanced p38 and JNK MAPK activation; homozygous Dusp16-deficient mice die perinatally.","method":"Gene trap mouse model, LPS challenge, cytokine ELISA, siRNA knockdown, pharmacological JNK inhibition, bone marrow reconstitution","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — gene trap KO mouse with multiple orthogonal methods and epistasis in vivo","pmids":["24311790"],"is_preprint":false},{"year":2014,"finding":"miR-17 upregulates DUSP16/MKP7 expression (by repressing ADCY5, causing RGS2 nuclear translocation that promotes MKP7 promoter activity); MKP7 inhibits cellular senescence by dephosphorylating PRAS40 at Thr246 and mTOR at Ser2248, facilitating their interaction and loss of function.","method":"miRNA transgenic mice, co-immunoprecipitation, western blot for phospho-PRAS40/mTOR, senescence assays, promoter-reporter assay","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — novel substrate identification (PRAS40, mTOR) with functional senescence readout","pmids":["25077541"],"is_preprint":false},{"year":2015,"finding":"DUSP16 ablation by shRNA causes G1/S transition arrest, cellular senescence (increased SA-β-gal, SAHF), and activates tumor suppressors p53 and Rb; the phosphatase catalytic activity of DUSP16 is required to antagonize cellular senescence.","method":"shRNA knockdown, cell cycle analysis (BrdU incorporation), SA-β-gal assay, phosphatase-dead mutant rescue","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with catalytic mutant rescue and multiple senescence readouts","pmids":["26381291"],"is_preprint":false},{"year":2017,"finding":"Dusp16 knockout mice develop congenital obstructive hydrocephalus and brain overgrowth; Dusp16 deficiency causes delayed cell cycle exit of neural progenitors in the midbrain aqueduct, leading to progenitor overproliferation and subsequent neuron overproduction and aqueduct obstruction.","method":"Dusp16−/− mouse model, BrdU/EdU incorporation, immunohistochemistry for progenitor/neuron markers, histological analysis of aqueduct","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO mouse with defined cellular phenotype in neurogenesis","pmids":["29170629"],"is_preprint":false},{"year":2018,"finding":"HIF-1 (hypoxia-inducible factor 1) decreases DUSP16 expression in response to chemotherapy in triple-negative breast cancer cells; reduced DUSP16 leads to p38 activation, which stabilizes Nanog and Klf4 mRNA via inactivating phosphorylation of ZFP36L1, promoting breast cancer stem cell enrichment.","method":"HIF1 siRNA knockdown, western blot, flow cytometry for BCSC markers, p38 inhibitor treatment","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis with HIF1/DUSP16/p38 pathway and stem cell phenotypic readout","pmids":["29880481"],"is_preprint":false},{"year":2020,"finding":"DUSP16 can directly interact with TAK1 in human hepatocytes; DUSP16 negatively regulates JNK, TAK1, and NF-κB signaling in response to palmitate; DUSP16 knockdown accelerates lipid deposition and inflammatory response, while DUSP16 overexpression has opposite effects; DUSP16 knockout in mice aggravates HFD-induced metabolic disorder.","method":"Co-immunoprecipitation (DUSP16–TAK1 interaction), siRNA knockdown, overexpression in primary hepatocytes, DUSP16-KO mouse model, western blot for phospho-JNK/TAK1/NF-κB","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding partner identified by Co-IP, confirmed in KO mouse model","pmids":["31982140"],"is_preprint":false},{"year":2021,"finding":"DUSP16 overexpression inhibits JNK and p38 activation, reducing BAX accumulation in mitochondria and decreasing chemotherapy-induced apoptosis; DUSP16 knockdown sensitizes cancer cells to chemotherapy-induced cell death via the mitochondrial apoptosis pathway.","method":"DUSP16 overexpression/knockdown, western blot for phospho-JNK/p38/BAX, mitochondrial fractionation, cell death assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — mechanistic dissection in multiple cancer cell lines with mitochondrial fractionation and pathway analysis","pmids":["33863904"],"is_preprint":false},{"year":2021,"finding":"NR4A1 transcriptionally enhances MKP7/DUSP16 expression by physically associating with two putative binding sites on the MKP7 promoter; MKP7 knockdown increases phospho-JNK in pancreatic β cells upon ER stress or ROS; NR4A1-KO mice show reduced MKP7 in pancreatic islets.","method":"NR4A1 KO mouse islets, promoter reporter assay with NR4A1 binding site mutations, siRNA knockdown, western blot for phospho-JNK","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 — direct transcriptional regulation with promoter binding confirmed and in vivo validation","pmids":["34088892"],"is_preprint":false},{"year":2022,"finding":"Tyrosine 271 (Y271) in the phosphatase domain of MKP7/DUSP16 is critical for catalytic activity and for binding to p38 MAPK and JNK1/2; Y271 mutants fail to dephosphorylate p38/JNK in cells and show reduced MAPK binding; WT MKP7 sequesters p38/JNK in the cytoplasm, but Y271 mutants fail to do so, resulting in greater nuclear accumulation of phospho-p38/JNK; this allosteric site is analogous to Y435 in MKP5.","method":"Site-directed mutagenesis, in-cell dephosphorylation assays, Co-IP for MAPK binding, immunofluorescence for MAPK localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — active-site mutagenesis with multiple functional readouts and structural analogy to MKP5","pmids":["36272649"],"is_preprint":false},{"year":2025,"finding":"FBXL18 physically interacts with DUSP16 and promotes its ubiquitination and proteasome-mediated degradation, thereby activating JNK/c-JUN signaling and promoting endometrial carcinoma cell proliferation, migration, and invasion; DUSP16 overexpression rescues FBXL18-mediated JNK activation.","method":"Co-immunoprecipitation, ubiquitination assay, western blot, loss/gain-of-function cell assays, rescue experiment","journal":"Cancer cell international","confidence":"Medium","confidence_rationale":"Tier 2 — direct E3 ligase–substrate relationship established by Co-IP and ubiquitination assay with rescue","pmids":["40382593"],"is_preprint":false}],"current_model":"DUSP16/MKP-7 is a cytoplasmic-enriched dual-specificity MAPK phosphatase that preferentially dephosphorylates JNK and p38α/β (but not ERK or p38γ/δ), shuttles between cytoplasm and nucleus via NES/NLS signals, sequesters phospho-ERK in the cytoplasm as a scaffold, is stabilized by ERK-mediated phosphorylation at Ser-446 (blocking proteasomal degradation by FBXL18-mediated ubiquitination), is inactivated by Mtb Eis-mediated Lys55 acetylation or eNOS-derived S-nitrosylation, and transcriptionally regulated by NR4A1, PPARδ (mRNA stabilization), and epigenetic methylation; through JNK/p38 inactivation it controls immune cytokine production (TLR-induced IL-12), Th1/Th2 balance, neural progenitor proliferation, chemotherapy-induced apoptosis via the mitochondrial BAX pathway, and cellular senescence through p53/Rb activation and PRAS40/mTOR dephosphorylation."},"narrative":{"teleology":[{"year":2001,"claim":"Identification of DUSP16/MKP-7 as a JNK/p38-selective phosphatase established its substrate specificity and distinguished it from ERK-directed DUSPs, answering the question of which MAPKs it targets.","evidence":"Co-immunoprecipitation and overexpression kinase assays in cultured cells, replicated independently in two labs","pmids":["11359773","11489891"],"confidence":"High","gaps":["Endogenous substrate preferences not confirmed at physiological expression levels","No structural basis for p38α/β vs p38γ/δ selectivity"]},{"year":2001,"claim":"Discovery that MKP-7 contains functional NES and NLS and shuttles between cytoplasm and nucleus resolved how a cytoplasmic phosphatase could be dynamically regulated by subcellular compartmentalization.","evidence":"Leptomycin B treatment, NES mutant expression, and subcellular fractionation in transfected cells","pmids":["11489891"],"confidence":"High","gaps":["Physiological signals triggering nuclear import were not identified","Whether shuttling changes substrate access in vivo was untested"]},{"year":2005,"claim":"Demonstrating that ERK phosphorylates DUSP16 at Ser-446 to stabilize it against proteasomal degradation revealed a cross-MAPK feedback loop and established the first mechanism controlling DUSP16 protein turnover.","evidence":"35S pulse-labeling, phospho-mimetic/deletion mutants, proteasome inhibitor treatment, and ubiquitin co-expression","pmids":["15689616"],"confidence":"High","gaps":["The E3 ubiquitin ligase responsible was not identified at this time","In vivo relevance of the feedback loop was not tested"]},{"year":2005,"claim":"Linking DUSP16 to the β-arrestin 2/JNK3 scaffold complex explained how DUSP16 accesses activated JNK3 in a receptor-regulated, spatially organized manner following AT1aR stimulation.","evidence":"Reciprocal Co-IP with domain mapping, receptor stimulation time-course, and immunofluorescence colocalization on endocytic vesicles","pmids":["15888437"],"confidence":"High","gaps":["Whether β-arrestin 2 interaction occurs for JNK1/2 substrates was not tested","Structural basis of the MKP7–β-arrestin interface unknown"]},{"year":2009,"claim":"Identification of S-nitrosylation by eNOS as an inactivating post-translational modification of DUSP16 established a redox-based regulatory mechanism linking NO signaling to JNK3-dependent endothelial migration.","evidence":"eNOS inhibition/knockdown, biotin-switch nitrosylation assay, and endothelial cell migration assay","pmids":["19307591"],"confidence":"High","gaps":["The specific cysteine residue(s) modified were not identified","Whether S-nitrosylation occurs in non-endothelial cell types was not explored"]},{"year":2010,"claim":"Showing that catalytically dead DUSP16 still sequesters phospho-ERK in the cytoplasm revealed a phosphatase-independent scaffold function, broadening DUSP16's role beyond enzymatic dephosphorylation.","evidence":"Phosphatase-dead mutant overexpression with immunofluorescence and reporter gene assays","pmids":["20122898"],"confidence":"Medium","gaps":["Physiological stoichiometry of DUSP16 vs ERK for scaffolding not assessed","Whether this scaffolding occurs under endogenous expression levels is unknown"]},{"year":2012,"claim":"Crystal structure-guided demonstration that Mtb Eis acetylates DUSP16 at Lys55 to suppress JNK-dependent autophagy and phagosome maturation provided a molecular mechanism for Mycobacterium immune evasion through host phosphatase inactivation.","evidence":"Crystal structures of Eis, in vitro acetyltransferase assays, site-directed mutagenesis, macrophage infection models","pmids":["22547814"],"confidence":"High","gaps":["Whether DUSP16 acetylation at Lys55 occurs from endogenous host acetyltransferases unknown","Contribution relative to other Eis substrates not quantified"]},{"year":2013,"claim":"Gene-trap Dusp16 knockout mice revealed perinatal lethality and selective overproduction of TLR-induced IL-12 in macrophages via JNK1/2, establishing DUSP16 as an essential, non-redundant regulator of innate immune cytokine production in vivo.","evidence":"Gene trap KO mice, LPS challenge, cytokine ELISA, JNK pharmacological inhibition and siRNA rescue, bone marrow reconstitution","pmids":["24311790"],"confidence":"High","gaps":["Cause of perinatal lethality not fully resolved (later attributed to hydrocephalus)","Whether other DUSPs compensate partially in specific tissues not determined"]},{"year":2011,"claim":"Selective expression of DUSP16 in Th2 cells and functional gain/loss experiments shifting Th1/Th2 balance established DUSP16 as an epigenetically regulated determinant of CD4+ T cell fate decisions.","evidence":"ChIP for histone acetylation at dusp16 promoter, adenoviral transduction with WT and dominant-negative DUSP16, transgenic mouse immunization","pmids":["21613215"],"confidence":"High","gaps":["MAPK substrate specificity in Th2 skewing (JNK vs p38 contribution) not delineated","Whether DUSP16 is required for Th2 identity or only promotes it is unclear"]},{"year":2014,"claim":"Identification of PRAS40 and mTOR as direct DUSP16 substrates (dephosphorylated at Thr246 and Ser2248 respectively) linked DUSP16 to senescence regulation beyond the canonical MAPK pathway.","evidence":"Co-immunoprecipitation, phospho-specific western blots for PRAS40/mTOR, senescence assays in miR-17 transgenic mice","pmids":["25077541"],"confidence":"Medium","gaps":["Direct in vitro phosphatase assay on PRAS40/mTOR not shown","Whether PRAS40/mTOR dephosphorylation is physiologically relevant outside senescence context unknown"]},{"year":2015,"claim":"Demonstrating that DUSP16 knockdown induces G1/S arrest and activates p53/Rb-dependent senescence, rescued only by catalytically active DUSP16, confirmed a phosphatase-dependent anti-senescence function.","evidence":"shRNA knockdown, BrdU incorporation, SA-β-gal assay, phosphatase-dead mutant rescue","pmids":["26381291"],"confidence":"Medium","gaps":["Whether the senescence phenotype is JNK/p38-dependent or PRAS40/mTOR-dependent not resolved","In vivo relevance to organismal aging not tested"]},{"year":2017,"claim":"Dusp16 knockout mice developing congenital obstructive hydrocephalus from neural progenitor overproliferation revealed the essential role of DUSP16 in timing cell cycle exit during brain development.","evidence":"Dusp16−/− mouse model, BrdU/EdU incorporation, immunohistochemistry for progenitor and neuron markers, aqueduct histology","pmids":["29170629"],"confidence":"Medium","gaps":["Which MAPK branch (JNK vs p38) drives progenitor overproliferation not determined","Whether this is the primary cause of perinatal lethality or one of multiple defects is uncertain"]},{"year":2021,"claim":"Establishing that DUSP16 suppresses chemotherapy-induced apoptosis by preventing BAX mitochondrial accumulation through JNK/p38 inactivation defined a targetable resistance mechanism in cancer cells.","evidence":"Overexpression/knockdown in multiple cancer cell lines, mitochondrial fractionation for BAX, phospho-MAPK western blots, cell death assays","pmids":["33863904"],"confidence":"High","gaps":["Relative contribution of JNK vs p38 to BAX translocation not separated","Whether DUSP16 targeting sensitizes tumors in vivo not demonstrated"]},{"year":2022,"claim":"Identification of Tyr271 as a critical allosteric residue required for both catalytic activity and p38/JNK binding and cytoplasmic sequestration clarified the structural basis for substrate engagement and anchoring.","evidence":"Site-directed mutagenesis of Y271, in-cell dephosphorylation assays, Co-IP for MAPK binding, immunofluorescence for MAPK localization","pmids":["36272649"],"confidence":"High","gaps":["Full crystal structure of DUSP16 phosphatase domain with bound MAPK substrate not available","Whether Y271 phosphorylation regulates activity in vivo unknown"]},{"year":2025,"claim":"Identification of FBXL18 as the E3 ubiquitin ligase that targets DUSP16 for proteasomal degradation closed a long-standing gap about which ligase controls DUSP16 turnover, connecting ubiquitin-proteasome regulation to JNK/c-JUN activation in cancer.","evidence":"Co-immunoprecipitation, ubiquitination assay, western blot, functional rescue of JNK activation by DUSP16 overexpression in endometrial carcinoma cells","pmids":["40382593"],"confidence":"Medium","gaps":["Whether FBXL18 recognizes the ERK-phosphorylated Ser-446 degron or an independent motif is unknown","In vivo validation of FBXL18–DUSP16 axis in animal models not performed"]},{"year":null,"claim":"Key unresolved questions include the full crystal structure of DUSP16 in complex with MAPK substrates, the identity of the S-nitrosylated cysteine(s), the relative contribution of JNK vs p38 to individual phenotypes (hydrocephalus, senescence, Th2 skewing), and whether the non-canonical substrates PRAS40/mTOR are direct physiological targets.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length DUSP16 crystal structure available","Cysteine target of S-nitrosylation unidentified","JNK vs p38 pathway contributions not genetically separated in most disease models"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,5,10,13,14,19,21]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[6,21]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1,6,11,21]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,11]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,5,6,13,18,19,21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,13]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[15,19]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[2,10,22]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[16]}],"complexes":[],"partners":["JNK1","JNK3","MAPK14","ARRB2","TAK1","FBXL18","ERK2","NR4A1"],"other_free_text":[]},"mechanistic_narrative":"DUSP16 (MKP-7) is a dual-specificity MAPK phosphatase that serves as a critical negative regulator of JNK and p38 signaling, thereby controlling inflammatory cytokine production, immune cell differentiation, neural progenitor proliferation, cellular senescence, and apoptotic responses. DUSP16 preferentially dephosphorylates JNK and p38α/β but not ERK, and additionally functions as a catalytic-activity-independent cytoplasmic anchor that sequesters phosphorylated ERK and prevents its nuclear translocation; a key allosteric tyrosine (Y271) in the phosphatase domain is required for both catalytic activity and substrate binding [PMID:11359773, PMID:20122898, PMID:36272649]. The protein shuttles between cytoplasm and nucleus via NES/NLS motifs and is regulated at multiple levels: ERK-mediated Ser-446 phosphorylation stabilizes it against FBXL18-directed proteasomal degradation, Mycobacterium tuberculosis Eis acetylates Lys55 to inactivate it, and eNOS-derived S-nitrosylation similarly blocks its activity [PMID:15689616, PMID:22547814, PMID:19307591, PMID:40382593]. Dusp16-deficient mice die perinatally with congenital obstructive hydrocephalus caused by neural progenitor overproliferation, and Dusp16-deficient macrophages overproduce TLR-induced cytokines including IL-12 through unrestrained JNK activation [PMID:29170629, PMID:24311790]."},"prefetch_data":{"uniprot":{"accession":"Q9BY84","full_name":"Dual specificity protein phosphatase 16","aliases":["Mitogen-activated protein kinase phosphatase 7","MAP kinase phosphatase 7","MKP-7"],"length_aa":665,"mass_kda":73.1,"function":"Dual specificity protein phosphatase involved in the inactivation of MAP kinases. Dephosphorylates MAPK10 bound to ARRB2","subcellular_location":"Cytoplasm; Nucleus; Cytoplasmic vesicle","url":"https://www.uniprot.org/uniprotkb/Q9BY84/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DUSP16","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DUSP16","total_profiled":1310},"omim":[{"mim_id":"607585","title":"ATM SERINE/THREONINE KINASE; ATM","url":"https://www.omim.org/entry/607585"},{"mim_id":"607175","title":"DUAL-SPECIFICITY PHOSPHATASE 16; DUSP16","url":"https://www.omim.org/entry/607175"},{"mim_id":"606992","title":"INOSITOL HEXAPHOSPHATE KINASE 2; IP6K2","url":"https://www.omim.org/entry/606992"},{"mim_id":"603423","title":"PR DOMAIN-CONTAINING PROTEIN 1; PRDM1","url":"https://www.omim.org/entry/603423"},{"mim_id":"133239","title":"ESOPHAGEAL CANCER","url":"https://www.omim.org/entry/133239"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DUSP16"},"hgnc":{"alias_symbol":["MKP-7","KIAA1700","MKP7"],"prev_symbol":[]},"alphafold":{"accession":"Q9BY84","domains":[{"cath_id":"3.40.250.10","chopping":"7-137","consensus_level":"high","plddt":89.0354,"start":7,"end":137},{"cath_id":"3.90.190.10","chopping":"159-300","consensus_level":"high","plddt":96.2642,"start":159,"end":300}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BY84","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BY84-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BY84-F1-predicted_aligned_error_v6.png","plddt_mean":60.28},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DUSP16","jax_strain_url":"https://www.jax.org/strain/search?query=DUSP16"},"sequence":{"accession":"Q9BY84","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BY84.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BY84/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BY84"}},"corpus_meta":[{"pmid":"22547814","id":"PMC_22547814","title":"Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22547814","citation_count":172,"is_preprint":false},{"pmid":"11359773","id":"PMC_11359773","title":"A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11359773","citation_count":136,"is_preprint":false},{"pmid":"11489891","id":"PMC_11489891","title":"MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11489891","citation_count":126,"is_preprint":false},{"pmid":"19826043","id":"PMC_19826043","title":"Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19826043","citation_count":100,"is_preprint":false},{"pmid":"29880481","id":"PMC_29880481","title":"Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29880481","citation_count":73,"is_preprint":false},{"pmid":"19307591","id":"PMC_19307591","title":"SDF-1alpha stimulates JNK3 activity via eNOS-dependent nitrosylation of MKP7 to enhance endothelial migration.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19307591","citation_count":68,"is_preprint":false},{"pmid":"33863904","id":"PMC_33863904","title":"DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33863904","citation_count":63,"is_preprint":false},{"pmid":"15689616","id":"PMC_15689616","title":"Phosphorylation of Ser-446 determines stability of MKP-7.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15689616","citation_count":55,"is_preprint":false},{"pmid":"21199832","id":"PMC_21199832","title":"Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity.","date":"2011","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/21199832","citation_count":54,"is_preprint":false},{"pmid":"25077541","id":"PMC_25077541","title":"miR-17 extends mouse lifespan by inhibiting senescence signaling mediated by MKP7.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25077541","citation_count":53,"is_preprint":false},{"pmid":"15888437","id":"PMC_15888437","title":"Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15888437","citation_count":51,"is_preprint":false},{"pmid":"14586399","id":"PMC_14586399","title":"MAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p12-13, reduces BCR-ABL-induced transformation.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14586399","citation_count":45,"is_preprint":false},{"pmid":"23280045","id":"PMC_23280045","title":"PI3K/Akt-independent negative regulation of JNK signaling by MKP-7 after cerebral ischemia in rat hippocampus.","date":"2013","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23280045","citation_count":40,"is_preprint":false},{"pmid":"33336891","id":"PMC_33336891","title":"Photobiomodulation suppresses JNK3 by activation of ERK/MKP7 to attenuate AMPA receptor endocytosis in Alzheimer's disease.","date":"2020","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/33336891","citation_count":34,"is_preprint":false},{"pmid":"29143999","id":"PMC_29143999","title":"MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29143999","citation_count":33,"is_preprint":false},{"pmid":"34663350","id":"PMC_34663350","title":"Exosomal transfer of miR-769-5p promotes osteosarcoma proliferation and metastasis by targeting DUSP16.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/34663350","citation_count":28,"is_preprint":false},{"pmid":"23639976","id":"PMC_23639976","title":"PPARδ inhibits UVB-induced secretion of MMP-1 through MKP-7-mediated suppression of JNK signaling.","date":"2013","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23639976","citation_count":28,"is_preprint":false},{"pmid":"20551953","id":"PMC_20551953","title":"DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma.","date":"2010","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20551953","citation_count":28,"is_preprint":false},{"pmid":"26381291","id":"PMC_26381291","title":"DUSP16 ablation arrests the cell cycle and induces cellular senescence.","date":"2015","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/26381291","citation_count":24,"is_preprint":false},{"pmid":"24311790","id":"PMC_24311790","title":"Gene trap mice reveal an essential function of dual specificity phosphatase Dusp16/MKP-7 in perinatal survival and regulation of Toll-like receptor (TLR)-induced cytokine production.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24311790","citation_count":24,"is_preprint":false},{"pmid":"21613215","id":"PMC_21613215","title":"Functional involvement of dual specificity phosphatase 16 (DUSP16), a c-Jun N-terminal kinase-specific phosphatase, in the regulation of T helper cell differentiation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21613215","citation_count":23,"is_preprint":false},{"pmid":"20122898","id":"PMC_20122898","title":"MKP-7, a JNK phosphatase, blocks ERK-dependent gene activation by anchoring phosphorylated ERK in the cytoplasm.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20122898","citation_count":18,"is_preprint":false},{"pmid":"27771463","id":"PMC_27771463","title":"Upregulation of MKP-7 in response to rosiglitazone treatment ameliorates lipopolysaccharide-induced destabilization of SIRT1 by inactivating JNK.","date":"2016","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/27771463","citation_count":17,"is_preprint":false},{"pmid":"35291714","id":"PMC_35291714","title":"circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury.","date":"2022","source":"Open medicine (Warsaw, Poland)","url":"https://pubmed.ncbi.nlm.nih.gov/35291714","citation_count":16,"is_preprint":false},{"pmid":"34088892","id":"PMC_34088892","title":"NR4A1 enhances MKP7 expression to diminish JNK activation induced by ROS or ER-stress in pancreatic β cells for surviving.","date":"2021","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34088892","citation_count":16,"is_preprint":false},{"pmid":"31982140","id":"PMC_31982140","title":"Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31982140","citation_count":15,"is_preprint":false},{"pmid":"29170629","id":"PMC_29170629","title":"Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool.","date":"2017","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29170629","citation_count":15,"is_preprint":false},{"pmid":"22182512","id":"PMC_22182512","title":"MKP-7, a negative regulator of JNK, regulates VCAM-1 expression through IRF-1.","date":"2011","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/22182512","citation_count":15,"is_preprint":false},{"pmid":"37878342","id":"PMC_37878342","title":"Mettl3 induced miR-338-3p expression in dendritic cells promotes antigen-specific Th17 cell response via regulation of Dusp16.","date":"2023","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/37878342","citation_count":13,"is_preprint":false},{"pmid":"34456589","id":"PMC_34456589","title":"CircRNA DUSP16 Knockdown Suppresses Colorectal Cancer Progression by Regulating the miR-432-5p/E2F6 Axis.","date":"2021","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/34456589","citation_count":13,"is_preprint":false},{"pmid":"25245988","id":"PMC_25245988","title":"Discovery of novel DUSP16 phosphatase inhibitors through virtual screening with homology modeled protein structure.","date":"2014","source":"Journal of biomolecular screening","url":"https://pubmed.ncbi.nlm.nih.gov/25245988","citation_count":9,"is_preprint":false},{"pmid":"36272649","id":"PMC_36272649","title":"A novel site on dual-specificity phosphatase MKP7/DUSP16 is required for catalysis and MAPK binding.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36272649","citation_count":8,"is_preprint":false},{"pmid":"24121342","id":"PMC_24121342","title":"A docking study of enhanced intracellular survival protein from Mycobacterium tuberculosis with human DUSP16/MKP-7.","date":"2013","source":"Journal of synchrotron radiation","url":"https://pubmed.ncbi.nlm.nih.gov/24121342","citation_count":7,"is_preprint":false},{"pmid":"38583797","id":"PMC_38583797","title":"Deficiency of smooth muscle cell ILF3 alleviates intimal hyperplasia via HMGB1 mRNA degradation-mediated regulation of the STAT3/DUSP16 axis.","date":"2024","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/38583797","citation_count":5,"is_preprint":false},{"pmid":"39434411","id":"PMC_39434411","title":"Suppressing DUSP16 overexpression induced by ELK1 promotes neural progenitor cell differentiation in mouse models of Alzheimer's disease.","date":"2024","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/39434411","citation_count":3,"is_preprint":false},{"pmid":"41320681","id":"PMC_41320681","title":"Regulatory roles of MKP7/DUSP16 in cancer.","date":"2025","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/41320681","citation_count":0,"is_preprint":false},{"pmid":"40382593","id":"PMC_40382593","title":"FBXL18 promotes endometrial carcinoma progression via destabilizing DUSP16 and thus activating JNK signaling pathway.","date":"2025","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/40382593","citation_count":0,"is_preprint":false},{"pmid":"41181635","id":"PMC_41181635","title":"SBEM confers paclitaxel resistance in breast cancer via DUSP16-mediated MAPK/AMPK pathway activation.","date":"2025","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/41181635","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21041,"output_tokens":5623,"usd":0.073734},"stage2":{"model":"claude-opus-4-6","input_tokens":9286,"output_tokens":3866,"usd":0.21462},"total_usd":0.288354,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"DUSP16/MKP-7 was identified as a novel dual-specificity phosphatase that binds to and inactivates JNK/SAPK and p38α/β MAPKs but not ERK; it is predominantly cytoplasmic when expressed in cultured cells; substrate specificity toward p38 isoforms was defined (α and β, but not γ or δ); the MAPK-docking site sequence was characterized.\",\n      \"method\": \"Co-immunoprecipitation, in-cell overexpression kinase assays, subcellular localization by immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — replicated independently in two papers (PMID:11359773 and PMID:11489891), multiple orthogonal methods\",\n      \"pmids\": [\"11359773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"DUSP16/MKP-7 contains both a nuclear export signal (NES) and a nuclear localization signal (NLS) in its C-terminal stretch, making it the first leptomycin B-sensitive shuttle MKP; it resides exclusively in the cytoplasm under basal conditions but redistributes to the nucleus upon leptomycin B treatment or NES mutation; co-immunoprecipitation showed MKP-7 retains JNK/p38 in the cytoplasm.\",\n      \"method\": \"Leptomycin B treatment, NES mutant expression, subcellular fractionation/immunofluorescence, Co-IP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in single paper, confirmed by independent lab (PMID:23280045)\",\n      \"pmids\": [\"11489891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ERK phosphorylates DUSP16/MKP-7 at Ser-446 in the C-terminal stretch (CTS), stabilizing the protein by reducing proteasome-mediated degradation; deletion of the CTS elongates MKP-7 half-life; MKP-7 is polyubiquitinated and degraded via the proteasome pathway.\",\n      \"method\": \"35S-pulse labeling, proteasome inhibitor treatment, phospho-mimetic/deletion mutant expression, ubiquitin co-expression assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro/cell-based mutational analysis with multiple orthogonal methods\",\n      \"pmids\": [\"15689616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DUSP16/MKP-7 binds the JNK3 scaffold protein β-arrestin 2 via MKP7 amino acids 394–443 (same region that interacts with JIP-1); MKP7 dephosphorylates JNK3 bound to β-arrestin 2 following ASK1 overexpression or AT1aR stimulation; AT1aR stimulation causes rapid (within 5 min) dissociation of MKP7 from β-arrestin 2, followed by reassociation on endocytic vesicles at 30–60 min.\",\n      \"method\": \"Co-immunoprecipitation, deletion mapping, receptor stimulation assays, immunofluorescence colocalization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with domain mapping and functional dephosphorylation readout\",\n      \"pmids\": [\"15888437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"miR-24 directly downregulates DUSP16/MKP-7, leading to enhanced phosphorylation of JNK and p38, stimulating myeloid cell proliferation and blocking granulocytic differentiation; this pathway is downstream of disrupted Runx1 subnuclear targeting.\",\n      \"method\": \"miRNA overexpression, western blot for phospho-JNK/p38, luciferase reporter, flow cytometry differentiation assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined cellular phenotype, direct miRNA-target validation\",\n      \"pmids\": [\"19826043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SDF-1α-induced activation of eNOS leads to S-nitrosylation of DUSP16/MKP7, rendering the phosphatase inactive, which permits JNK3 activation required for endothelial cell migration.\",\n      \"method\": \"eNOS inhibition/knockdown, nitrosylation assay, JNK3 activity assay, endothelial migration assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct post-translational modification (S-nitrosylation) identified with functional consequence and epistasis\",\n      \"pmids\": [\"19307591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MKP-7/DUSP16 blocks ERK-dependent nuclear gene activation by anchoring phosphorylated ERK in the cytoplasm, independent of its phosphatase catalytic activity toward ERK; a phosphatase-dead MKP-7 mutant similarly prolongs mitogen-induced ERK phosphorylation and prevents nuclear accumulation of phospho-ERK.\",\n      \"method\": \"Phosphatase-dead mutant overexpression, immunofluorescence colocalization, reporter gene assay, time-course ERK phosphorylation assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional mutant analysis with multiple readouts in a single lab\",\n      \"pmids\": [\"20122898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DUSP16 expression is silenced by CpG island methylation in Burkitt's lymphoma (BL), which abrogates a negative feedback loop limiting JNK activity; in BL cell lines with DUSP16 methylation, JNK activation is increased, and cells show enhanced sensitivity to JNK-activating agents.\",\n      \"method\": \"Bisulfite sequencing, methylation-specific PCR, western blot with phospho-JNK antibody, siRNA knockdown\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epigenetic mechanism identified with functional JNK pathway readout\",\n      \"pmids\": [\"20551953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DUSP16 is selectively expressed in Th2 cells via histone H3/H4 acetylation at the dusp16 promoter; adenoviral overexpression of DUSP16 in naïve CD4+ T cells increased IL-4 and GATA-3 in Th2 and decreased IFNγ and T-bet in Th1 differentiation; dominant-negative DUSP16 had opposite effects; phosphatase activity is required for Th1/Th2 balance.\",\n      \"method\": \"ChIP, adenoviral transduction, dominant-negative mutant, cytokine ELISA, transgenic mouse immunization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including in vivo transgenic model and gain/loss-of-function\",\n      \"pmids\": [\"21613215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MKP-7/DUSP16 silencing by siRNA increased phospho-JNK and inhibited VCAM-1 (but not ICAM-1) expression in TNF-α-stimulated endothelial cells; this regulation was mediated via IRF-1 binding to the VCAM-1 promoter, as confirmed by ChIP assay.\",\n      \"method\": \"siRNA knockdown, western blot, ChIP assay, flow cytometry\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown with ChIP-based pathway placement\",\n      \"pmids\": [\"22182512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mtb Eis protein acetylates Lys55 of DUSP16/MKP-7 (Nε-acetylation), which inhibits LPS-induced JNK phosphorylation; crystal structures of both Mtb and Msm Eis proteins explain the differential selectivity; this acetylation suppresses JNK-dependent autophagy, phagosome maturation, and ROS generation in macrophages.\",\n      \"method\": \"Biochemical acetyltransferase assay, crystal structure determination, site-directed mutagenesis, western blot for phospho-JNK, macrophage infection models\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus in vitro biochemistry and mutagenesis with functional readout\",\n      \"pmids\": [\"22547814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In a rat cerebral ischemia/reperfusion model, MKP-7 is upregulated at 4 h reperfusion; MKP-7 nuclear export is required for cytoplasmic JNK inactivation (leptomycin B blocking nuclear export upregulated JNK activity); MKP-7 regulates JNK independently of the PI3K/Akt pathway.\",\n      \"method\": \"siRNA knockdown, cycloheximide treatment, leptomycin B treatment, subcellular fractionation, western blot for phospho-JNK in rat ischemia model\",\n      \"journal\": \"BMC neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo model with pharmacological and genetic perturbations\",\n      \"pmids\": [\"23280045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PPARδ activation stabilizes DUSP16/MKP-7 mRNA (post-transcriptional mRNA stabilization), leading to suppression of JNK signaling and reduced UVB-induced MMP-1 secretion in human dermal fibroblasts and hairless mice.\",\n      \"method\": \"PPARδ siRNA knockdown, specific ligand treatment, western blot, mRNA stability assay, in vivo mouse model\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mRNA stabilization mechanism with loss-of-function and in vivo confirmation\",\n      \"pmids\": [\"23639976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Dusp16-deficient macrophages show selective overproduction of a subset of TLR-induced cytokines (including IL-12), mediated through enhanced JNK1/2 activation; JNK1/2 pharmacological inhibition or siRNA knockdown normalizes IL-12p40 secretion; Dusp16-deficient fibroblasts show enhanced p38 and JNK MAPK activation; homozygous Dusp16-deficient mice die perinatally.\",\n      \"method\": \"Gene trap mouse model, LPS challenge, cytokine ELISA, siRNA knockdown, pharmacological JNK inhibition, bone marrow reconstitution\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gene trap KO mouse with multiple orthogonal methods and epistasis in vivo\",\n      \"pmids\": [\"24311790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-17 upregulates DUSP16/MKP7 expression (by repressing ADCY5, causing RGS2 nuclear translocation that promotes MKP7 promoter activity); MKP7 inhibits cellular senescence by dephosphorylating PRAS40 at Thr246 and mTOR at Ser2248, facilitating their interaction and loss of function.\",\n      \"method\": \"miRNA transgenic mice, co-immunoprecipitation, western blot for phospho-PRAS40/mTOR, senescence assays, promoter-reporter assay\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — novel substrate identification (PRAS40, mTOR) with functional senescence readout\",\n      \"pmids\": [\"25077541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DUSP16 ablation by shRNA causes G1/S transition arrest, cellular senescence (increased SA-β-gal, SAHF), and activates tumor suppressors p53 and Rb; the phosphatase catalytic activity of DUSP16 is required to antagonize cellular senescence.\",\n      \"method\": \"shRNA knockdown, cell cycle analysis (BrdU incorporation), SA-β-gal assay, phosphatase-dead mutant rescue\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with catalytic mutant rescue and multiple senescence readouts\",\n      \"pmids\": [\"26381291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Dusp16 knockout mice develop congenital obstructive hydrocephalus and brain overgrowth; Dusp16 deficiency causes delayed cell cycle exit of neural progenitors in the midbrain aqueduct, leading to progenitor overproliferation and subsequent neuron overproduction and aqueduct obstruction.\",\n      \"method\": \"Dusp16−/− mouse model, BrdU/EdU incorporation, immunohistochemistry for progenitor/neuron markers, histological analysis of aqueduct\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO mouse with defined cellular phenotype in neurogenesis\",\n      \"pmids\": [\"29170629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HIF-1 (hypoxia-inducible factor 1) decreases DUSP16 expression in response to chemotherapy in triple-negative breast cancer cells; reduced DUSP16 leads to p38 activation, which stabilizes Nanog and Klf4 mRNA via inactivating phosphorylation of ZFP36L1, promoting breast cancer stem cell enrichment.\",\n      \"method\": \"HIF1 siRNA knockdown, western blot, flow cytometry for BCSC markers, p38 inhibitor treatment\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with HIF1/DUSP16/p38 pathway and stem cell phenotypic readout\",\n      \"pmids\": [\"29880481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DUSP16 can directly interact with TAK1 in human hepatocytes; DUSP16 negatively regulates JNK, TAK1, and NF-κB signaling in response to palmitate; DUSP16 knockdown accelerates lipid deposition and inflammatory response, while DUSP16 overexpression has opposite effects; DUSP16 knockout in mice aggravates HFD-induced metabolic disorder.\",\n      \"method\": \"Co-immunoprecipitation (DUSP16–TAK1 interaction), siRNA knockdown, overexpression in primary hepatocytes, DUSP16-KO mouse model, western blot for phospho-JNK/TAK1/NF-κB\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding partner identified by Co-IP, confirmed in KO mouse model\",\n      \"pmids\": [\"31982140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DUSP16 overexpression inhibits JNK and p38 activation, reducing BAX accumulation in mitochondria and decreasing chemotherapy-induced apoptosis; DUSP16 knockdown sensitizes cancer cells to chemotherapy-induced cell death via the mitochondrial apoptosis pathway.\",\n      \"method\": \"DUSP16 overexpression/knockdown, western blot for phospho-JNK/p38/BAX, mitochondrial fractionation, cell death assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection in multiple cancer cell lines with mitochondrial fractionation and pathway analysis\",\n      \"pmids\": [\"33863904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NR4A1 transcriptionally enhances MKP7/DUSP16 expression by physically associating with two putative binding sites on the MKP7 promoter; MKP7 knockdown increases phospho-JNK in pancreatic β cells upon ER stress or ROS; NR4A1-KO mice show reduced MKP7 in pancreatic islets.\",\n      \"method\": \"NR4A1 KO mouse islets, promoter reporter assay with NR4A1 binding site mutations, siRNA knockdown, western blot for phospho-JNK\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct transcriptional regulation with promoter binding confirmed and in vivo validation\",\n      \"pmids\": [\"34088892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Tyrosine 271 (Y271) in the phosphatase domain of MKP7/DUSP16 is critical for catalytic activity and for binding to p38 MAPK and JNK1/2; Y271 mutants fail to dephosphorylate p38/JNK in cells and show reduced MAPK binding; WT MKP7 sequesters p38/JNK in the cytoplasm, but Y271 mutants fail to do so, resulting in greater nuclear accumulation of phospho-p38/JNK; this allosteric site is analogous to Y435 in MKP5.\",\n      \"method\": \"Site-directed mutagenesis, in-cell dephosphorylation assays, Co-IP for MAPK binding, immunofluorescence for MAPK localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — active-site mutagenesis with multiple functional readouts and structural analogy to MKP5\",\n      \"pmids\": [\"36272649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FBXL18 physically interacts with DUSP16 and promotes its ubiquitination and proteasome-mediated degradation, thereby activating JNK/c-JUN signaling and promoting endometrial carcinoma cell proliferation, migration, and invasion; DUSP16 overexpression rescues FBXL18-mediated JNK activation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, western blot, loss/gain-of-function cell assays, rescue experiment\",\n      \"journal\": \"Cancer cell international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct E3 ligase–substrate relationship established by Co-IP and ubiquitination assay with rescue\",\n      \"pmids\": [\"40382593\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DUSP16/MKP-7 is a cytoplasmic-enriched dual-specificity MAPK phosphatase that preferentially dephosphorylates JNK and p38α/β (but not ERK or p38γ/δ), shuttles between cytoplasm and nucleus via NES/NLS signals, sequesters phospho-ERK in the cytoplasm as a scaffold, is stabilized by ERK-mediated phosphorylation at Ser-446 (blocking proteasomal degradation by FBXL18-mediated ubiquitination), is inactivated by Mtb Eis-mediated Lys55 acetylation or eNOS-derived S-nitrosylation, and transcriptionally regulated by NR4A1, PPARδ (mRNA stabilization), and epigenetic methylation; through JNK/p38 inactivation it controls immune cytokine production (TLR-induced IL-12), Th1/Th2 balance, neural progenitor proliferation, chemotherapy-induced apoptosis via the mitochondrial BAX pathway, and cellular senescence through p53/Rb activation and PRAS40/mTOR dephosphorylation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DUSP16 (MKP-7) is a dual-specificity MAPK phosphatase that serves as a critical negative regulator of JNK and p38 signaling, thereby controlling inflammatory cytokine production, immune cell differentiation, neural progenitor proliferation, cellular senescence, and apoptotic responses. DUSP16 preferentially dephosphorylates JNK and p38α/β but not ERK, and additionally functions as a catalytic-activity-independent cytoplasmic anchor that sequesters phosphorylated ERK and prevents its nuclear translocation; a key allosteric tyrosine (Y271) in the phosphatase domain is required for both catalytic activity and substrate binding [PMID:11359773, PMID:20122898, PMID:36272649]. The protein shuttles between cytoplasm and nucleus via NES/NLS motifs and is regulated at multiple levels: ERK-mediated Ser-446 phosphorylation stabilizes it against FBXL18-directed proteasomal degradation, Mycobacterium tuberculosis Eis acetylates Lys55 to inactivate it, and eNOS-derived S-nitrosylation similarly blocks its activity [PMID:15689616, PMID:22547814, PMID:19307591, PMID:40382593]. Dusp16-deficient mice die perinatally with congenital obstructive hydrocephalus caused by neural progenitor overproliferation, and Dusp16-deficient macrophages overproduce TLR-induced cytokines including IL-12 through unrestrained JNK activation [PMID:29170629, PMID:24311790].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of DUSP16/MKP-7 as a JNK/p38-selective phosphatase established its substrate specificity and distinguished it from ERK-directed DUSPs, answering the question of which MAPKs it targets.\",\n      \"evidence\": \"Co-immunoprecipitation and overexpression kinase assays in cultured cells, replicated independently in two labs\",\n      \"pmids\": [\"11359773\", \"11489891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous substrate preferences not confirmed at physiological expression levels\", \"No structural basis for p38α/β vs p38γ/δ selectivity\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovery that MKP-7 contains functional NES and NLS and shuttles between cytoplasm and nucleus resolved how a cytoplasmic phosphatase could be dynamically regulated by subcellular compartmentalization.\",\n      \"evidence\": \"Leptomycin B treatment, NES mutant expression, and subcellular fractionation in transfected cells\",\n      \"pmids\": [\"11489891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological signals triggering nuclear import were not identified\", \"Whether shuttling changes substrate access in vivo was untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that ERK phosphorylates DUSP16 at Ser-446 to stabilize it against proteasomal degradation revealed a cross-MAPK feedback loop and established the first mechanism controlling DUSP16 protein turnover.\",\n      \"evidence\": \"35S pulse-labeling, phospho-mimetic/deletion mutants, proteasome inhibitor treatment, and ubiquitin co-expression\",\n      \"pmids\": [\"15689616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The E3 ubiquitin ligase responsible was not identified at this time\", \"In vivo relevance of the feedback loop was not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Linking DUSP16 to the β-arrestin 2/JNK3 scaffold complex explained how DUSP16 accesses activated JNK3 in a receptor-regulated, spatially organized manner following AT1aR stimulation.\",\n      \"evidence\": \"Reciprocal Co-IP with domain mapping, receptor stimulation time-course, and immunofluorescence colocalization on endocytic vesicles\",\n      \"pmids\": [\"15888437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether β-arrestin 2 interaction occurs for JNK1/2 substrates was not tested\", \"Structural basis of the MKP7–β-arrestin interface unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of S-nitrosylation by eNOS as an inactivating post-translational modification of DUSP16 established a redox-based regulatory mechanism linking NO signaling to JNK3-dependent endothelial migration.\",\n      \"evidence\": \"eNOS inhibition/knockdown, biotin-switch nitrosylation assay, and endothelial cell migration assay\",\n      \"pmids\": [\"19307591\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific cysteine residue(s) modified were not identified\", \"Whether S-nitrosylation occurs in non-endothelial cell types was not explored\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showing that catalytically dead DUSP16 still sequesters phospho-ERK in the cytoplasm revealed a phosphatase-independent scaffold function, broadening DUSP16's role beyond enzymatic dephosphorylation.\",\n      \"evidence\": \"Phosphatase-dead mutant overexpression with immunofluorescence and reporter gene assays\",\n      \"pmids\": [\"20122898\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological stoichiometry of DUSP16 vs ERK for scaffolding not assessed\", \"Whether this scaffolding occurs under endogenous expression levels is unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Crystal structure-guided demonstration that Mtb Eis acetylates DUSP16 at Lys55 to suppress JNK-dependent autophagy and phagosome maturation provided a molecular mechanism for Mycobacterium immune evasion through host phosphatase inactivation.\",\n      \"evidence\": \"Crystal structures of Eis, in vitro acetyltransferase assays, site-directed mutagenesis, macrophage infection models\",\n      \"pmids\": [\"22547814\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DUSP16 acetylation at Lys55 occurs from endogenous host acetyltransferases unknown\", \"Contribution relative to other Eis substrates not quantified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Gene-trap Dusp16 knockout mice revealed perinatal lethality and selective overproduction of TLR-induced IL-12 in macrophages via JNK1/2, establishing DUSP16 as an essential, non-redundant regulator of innate immune cytokine production in vivo.\",\n      \"evidence\": \"Gene trap KO mice, LPS challenge, cytokine ELISA, JNK pharmacological inhibition and siRNA rescue, bone marrow reconstitution\",\n      \"pmids\": [\"24311790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cause of perinatal lethality not fully resolved (later attributed to hydrocephalus)\", \"Whether other DUSPs compensate partially in specific tissues not determined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Selective expression of DUSP16 in Th2 cells and functional gain/loss experiments shifting Th1/Th2 balance established DUSP16 as an epigenetically regulated determinant of CD4+ T cell fate decisions.\",\n      \"evidence\": \"ChIP for histone acetylation at dusp16 promoter, adenoviral transduction with WT and dominant-negative DUSP16, transgenic mouse immunization\",\n      \"pmids\": [\"21613215\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"MAPK substrate specificity in Th2 skewing (JNK vs p38 contribution) not delineated\", \"Whether DUSP16 is required for Th2 identity or only promotes it is unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of PRAS40 and mTOR as direct DUSP16 substrates (dephosphorylated at Thr246 and Ser2248 respectively) linked DUSP16 to senescence regulation beyond the canonical MAPK pathway.\",\n      \"evidence\": \"Co-immunoprecipitation, phospho-specific western blots for PRAS40/mTOR, senescence assays in miR-17 transgenic mice\",\n      \"pmids\": [\"25077541\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct in vitro phosphatase assay on PRAS40/mTOR not shown\", \"Whether PRAS40/mTOR dephosphorylation is physiologically relevant outside senescence context unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that DUSP16 knockdown induces G1/S arrest and activates p53/Rb-dependent senescence, rescued only by catalytically active DUSP16, confirmed a phosphatase-dependent anti-senescence function.\",\n      \"evidence\": \"shRNA knockdown, BrdU incorporation, SA-β-gal assay, phosphatase-dead mutant rescue\",\n      \"pmids\": [\"26381291\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the senescence phenotype is JNK/p38-dependent or PRAS40/mTOR-dependent not resolved\", \"In vivo relevance to organismal aging not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Dusp16 knockout mice developing congenital obstructive hydrocephalus from neural progenitor overproliferation revealed the essential role of DUSP16 in timing cell cycle exit during brain development.\",\n      \"evidence\": \"Dusp16−/− mouse model, BrdU/EdU incorporation, immunohistochemistry for progenitor and neuron markers, aqueduct histology\",\n      \"pmids\": [\"29170629\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Which MAPK branch (JNK vs p38) drives progenitor overproliferation not determined\", \"Whether this is the primary cause of perinatal lethality or one of multiple defects is uncertain\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Establishing that DUSP16 suppresses chemotherapy-induced apoptosis by preventing BAX mitochondrial accumulation through JNK/p38 inactivation defined a targetable resistance mechanism in cancer cells.\",\n      \"evidence\": \"Overexpression/knockdown in multiple cancer cell lines, mitochondrial fractionation for BAX, phospho-MAPK western blots, cell death assays\",\n      \"pmids\": [\"33863904\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of JNK vs p38 to BAX translocation not separated\", \"Whether DUSP16 targeting sensitizes tumors in vivo not demonstrated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of Tyr271 as a critical allosteric residue required for both catalytic activity and p38/JNK binding and cytoplasmic sequestration clarified the structural basis for substrate engagement and anchoring.\",\n      \"evidence\": \"Site-directed mutagenesis of Y271, in-cell dephosphorylation assays, Co-IP for MAPK binding, immunofluorescence for MAPK localization\",\n      \"pmids\": [\"36272649\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full crystal structure of DUSP16 phosphatase domain with bound MAPK substrate not available\", \"Whether Y271 phosphorylation regulates activity in vivo unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identification of FBXL18 as the E3 ubiquitin ligase that targets DUSP16 for proteasomal degradation closed a long-standing gap about which ligase controls DUSP16 turnover, connecting ubiquitin-proteasome regulation to JNK/c-JUN activation in cancer.\",\n      \"evidence\": \"Co-immunoprecipitation, ubiquitination assay, western blot, functional rescue of JNK activation by DUSP16 overexpression in endometrial carcinoma cells\",\n      \"pmids\": [\"40382593\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether FBXL18 recognizes the ERK-phosphorylated Ser-446 degron or an independent motif is unknown\", \"In vivo validation of FBXL18–DUSP16 axis in animal models not performed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the full crystal structure of DUSP16 in complex with MAPK substrates, the identity of the S-nitrosylated cysteine(s), the relative contribution of JNK vs p38 to individual phenotypes (hydrocephalus, senescence, Th2 skewing), and whether the non-canonical substrates PRAS40/mTOR are direct physiological targets.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length DUSP16 crystal structure available\", \"Cysteine target of S-nitrosylation unidentified\", \"JNK vs p38 pathway contributions not genetically separated in most disease models\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 5, 10, 13, 14, 19, 21]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [6, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1, 6, 11, 21]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 11]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 5, 6, 13, 18, 19, 21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 13]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [15, 19]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [2, 10, 22]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"JNK1\",\n      \"JNK3\",\n      \"MAPK14\",\n      \"ARRB2\",\n      \"TAK1\",\n      \"FBXL18\",\n      \"ERK2\",\n      \"NR4A1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}